Cargando…
Antidiabetic Agent DPP-4i Facilitates Murine Breast Cancer Metastasis by Oncogenic ROS-NRF2-HO-1 Axis via a Positive NRF2-HO-1 Feedback Loop
Cancer has been as one of common comorbidities of diabetes. Long-term antidiabetic treatment may potentially exert uncertain impacts on diabetic patients with cancer including breast cancer (BC). Dipeptidyl peptidase-4 inhibitors (DPP-4i) are currently recommended by the AACE as first-line hypoglyce...
Autores principales: | Li, Rui, Zeng, Xin, Yang, Meihua, Xu, Xiaohui, Feng, Jinmei, Bao, Liming, Xue, Bingqian, Wang, Xin, Huang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187865/ https://www.ncbi.nlm.nih.gov/pubmed/34123848 http://dx.doi.org/10.3389/fonc.2021.679816 |
Ejemplares similares
-
Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases
por: Mansouri, Atena, et al.
Publicado: (2022) -
Antidiabetic DPP-4 Inhibitors Reprogram Tumor Microenvironment That Facilitates Murine Breast Cancer Metastasis Through Interaction With Cancer Cells via a ROS–NF-кB–NLRP3 Axis
por: Li, Rui, et al.
Publicado: (2021) -
The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance
por: Furfaro, A. L., et al.
Publicado: (2016) -
Modulation of Nrf2/HO-1 by Natural Compounds in Lung Cancer
por: Ghareghomi, Somayyeh, et al.
Publicado: (2023) -
Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib
por: Furfaro, A. L., et al.
Publicado: (2016)